%0 Journal Article
%T Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
%A Diane Goltz
%A Dimo Dietrich
%A Glen Kristiansen
%A Heidrun Gevensleben
%A Jennifer Landsberg
%A J£¿rg Ellinger
%A J£¿rn Dietrich
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1221555
%K DNA methylation
%K PD-1
%K PDCD1
%K prognostic biomarker
%K prostate cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087295/